ClinConnect ClinConnect Logo
Search / Trial NCT06974019

Empathy Through Pain Control: Buffered Compared to Unbuffered 1% Lidocaine During IUD Placement

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · May 7, 2025

Trial Information

Current as of July 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different types of numbing medicine can affect pain levels during the placement of an IUD (a small device used for birth control). Specifically, the researchers want to see if a "buffered" version of lidocaine, which includes a small amount of sodium bicarbonate, is more effective at reducing pain compared to the regular (or "unbuffered") lidocaine. The study will also look at how patients feel about the empathy shown by their healthcare providers during the procedure.

To participate in this trial, women aged 18 to 50 who have never given birth (known as nulliparous women) and are seeking an IUD can apply. Participants should be able to speak English and provide informed consent. Importantly, they should not have a history of certain medical conditions, including chronic pain, substance use disorders, or any current pregnancy. If eligible, participants can expect to receive either the buffered or unbuffered lidocaine before their IUD placement, and their pain levels and experiences will be evaluated throughout the process. This research aims to improve the comfort and care women receive during this important procedure.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Ability to provide informed consent
  • 2. Women IUD placement for contraception or heavy menstrual bleeding
  • 3. Ages 18-50
  • 4. English-speaking
  • 5. Participants must not have a past medical history of substance use disorders, pain disorders, use of prescription pain medications or are found to be pregnant
  • 6. Nulliparous (never given birth)
  • Exclusion Criteria:
  • 1. History of ever giving birth
  • 2. Current use of prescription pain medication prior to procedure. Over-the-counter medications such as those containing ibuprofen, aspirin, acetaminophen, or naproxen are allowed.
  • 3. Diagnosed chronic pain condition
  • 4. Current pregnancy
  • 5. Known allergic reactions to components of the local anesthetic
  • 6. History of an IUD placement
  • 7. Current substance use or history of substance use
  • 8. Known contraindications to IUD, such as unexplained vaginal bleeding

About University Of California, San Diego

The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.

Locations

Patients applied

0 patients applied

Trial Officials

Sheila K Mody, MD, MPH

Principal Investigator

UC San Diego

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported